{"transactions":[{"id":1244450,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82793,"kind":"person","name":"van der Horst Edward","position":1,"cik":"0001957499","reported_name":"van der Horst Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-02-26T23:44:32.000Z","date":"2025-02-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2276,"price":0.476,"value":1083.376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 6,000 shares purchased by the Reporting Person since May 16, 2024 pursuant to the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":59794,"source":{"system":"sec-edgar","filing":"0001415889-25-005727","document":"form4-02262025_110225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588925005727/form4-02262025_110225.xml","form_type":"4"}},{"id":1268600,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82793,"kind":"person","name":"van der Horst Edward","position":1,"cik":"0001957499","reported_name":"van der Horst Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:01:56.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 14, 2026, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":110000,"derivative":{"exercise_price":0.476,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001415889-25-004222","document":"form4-02142025_110252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588925004222/form4-02142025_110252.xml","form_type":"4"}},{"id":1323499,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82793,"kind":"person","name":"van der Horst Edward","position":1,"cik":"0001957499","reported_name":"van der Horst Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-23T21:15:30.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on December 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of such date."}],"balance_after":100000,"derivative":{"exercise_price":0.4499,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-24-030069","document":"form4-12232024_041227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588924030069/form4-12232024_041227.xml","form_type":"4"}},{"id":1639763,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82793,"kind":"person","name":"van der Horst Edward","position":1,"cik":"0001957499","reported_name":"van der Horst Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T23:37:03.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":90102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents one-third of the Reporting Person's 2023 annual bonus, which the Compensation Committee of the Issuer determined to pay in the form of a stock option in lieu of cash. 100% of the shares are fully vested as of the date of grant."}],"balance_after":90102,"derivative":{"exercise_price":0.79,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":90102},"source":{"system":"sec-edgar","filing":"0001415889-24-004236","document":"form4-02162024_110255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588924004236/form4-02162024_110255.xml","form_type":"4"}},{"id":1639762,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82793,"kind":"person","name":"van der Horst Edward","position":1,"cik":"0001957499","reported_name":"van der Horst Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T23:37:03.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 15, 2025, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":125000,"derivative":{"exercise_price":0.79,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-24-004236","document":"form4-02162024_110255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588924004236/form4-02162024_110255.xml","form_type":"4"}},{"id":1639761,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82793,"kind":"person","name":"van der Horst Edward","position":1,"cik":"0001957499","reported_name":"van der Horst Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-02-16T23:37:03.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2843,"price":0.79,"value":2245.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 6,000 shares purchased by the Reporting Person since May 16, 2023 pursuant to the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":56070,"source":{"system":"sec-edgar","filing":"0001415889-24-004236","document":"form4-02162024_110255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588924004236/form4-02162024_110255.xml","form_type":"4"}},{"id":1784231,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82793,"kind":"person","name":"van der Horst Edward","position":1,"cik":"0001957499","reported_name":"van der Horst Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-09-11T21:33:50.000Z","date":"2023-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9525,"price":1.5,"value":14287.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":52913,"source":{"system":"sec-edgar","filing":"0001209191-23-048967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123048967/doc4.xml","form_type":"4"}},{"id":2009502,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82793,"kind":"person","name":"van der Horst Edward","position":1,"cik":"0001957499","reported_name":"van der Horst Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-17T22:01:41.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 15, 2024, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":75000,"derivative":{"exercise_price":1.43,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-23-010736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123010736/doc4.xml","form_type":"4"}},{"id":2009501,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82793,"kind":"person","name":"van der Horst Edward","position":1,"cik":"0001957499","reported_name":"van der Horst Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-17T22:01:41.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":17700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent RSUs. Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in four equal annual installments on each of February 15, 2024, February 15, 2025, February 15, 2026 and February 15, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":62438,"source":{"system":"sec-edgar","filing":"0001209191-23-010736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123010736/doc4.xml","form_type":"4"}},{"id":2009500,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":82793,"kind":"person","name":"van der Horst Edward","position":1,"cik":"0001957499","reported_name":"van der Horst Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-17T22:01:41.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":23565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs are fully vested."}],"balance_after":44738,"source":{"system":"sec-edgar","filing":"0001209191-23-010736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123010736/doc4.xml","form_type":"4"}}]}